Athens Medical Center S.A - Iatriko Amarousiou

Marousi 15125

1 studies enrolling now · 2 studies all time

What they study most

Metastatic Castration-resistant Prostate Cancer, Type 2 Diabetes Mellitus (T2DM)

Studies at this site

• A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer — Recruiting now
• A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM) — Running, not enrolling